Published guidance document that aims to help unaffected pathogenic variant carriers and their treating physicians navigate the complexity of clinical care during the pre-symptomatic stage of disease.
Emanated from the workshop on clinical care management of pre-symptomatic carriers at elevated genetic risk for ALS/FTD (Sept 2023).
Podcast:
Recent Comments